Abstract:Aim: To develop and evaluate a whole-body physiologically based pharmacokinetic (WB-PBPK) model of bisoprolol and to simulate its exposure and disposition in healthy adults and patients with renal function impairment.Methods: Bisoprolol dispositions in 14 tissue compartments were described by perfusion-limited compartments. Based the tissue composition equations and drug-specific properties such as log P, permeability, and plasma protein binding published in literatures, the absorption and whole-body distribution of bisoprolol was predicted using the 'Advanced Compartmental Absorption Transit' (ACAT) model and the whole-body disposition model, respectively. Renal and hepatic clearances were simulated using empirical scaling methods followed by incorporation into the WB-PBPK model. Model refinements were conducted after a comparison of the simulated concentration-time profiles and pharmacokinetic parameters with the observed data in healthy adults following intravenous and oral administration. Finally, the WB-PBPK model coupled with a Monte Carlo simulation was employed to predict the mean and variability of bisoprolol pharmacokinetics in virtual healthy subjects and patients.Results: The simulated and observed data after both intravenous and oral dosing showed good agreement for all of the dose levels in the reported normal adult population groups. The predicted pharmacokinetic parameters (AUC, C-max, and T-max) were reasonably consistent (<1.3-fold error) with the observed values after single oral administration of doses ranging from of 5 to 20 mg using the refined WB-PBPK model. The simulated plasma profiles after multiple oral administration of bisoprolol in healthy adults and patient with renal impairment matched well with the observed profiles.Conclusion: The WB-PBPK model successfully predicts the intravenous and oral pharmacokinetics of bisoprolol across multiple dose levels in diverse normal adult human populations and patients with renal insufficiency.

The Simulation of the Influence of Two-Compartment Model Parameters on the Plasma Drug Concentration and Drug Effect

Mathematical Model of the Dynamics of Countercurrent Chromatography

Application of Ivive and Pbpk Modeling in Prospective Prediction of Clinical Pharmacokinetics: Strategy and Approach During the Drug Discovery Phase with Four Case Studies

A fuzzy neartude based approach to simulate the two-compartment pharmacokinetic model

Exploring the Impact of Pharmacological Target-Mediated Low Plasma Exposure in Lead Compound Selection in Drug Discovery – A Modeling Approach

Statistical Analysis of Two-Compartment Pharmacokinetic Models with Drug Non-adherence

Thermodynamics and Kinetics of Drug-Target Binding by Molecular Simulation

A method to determine pharmacokinetic parameters based on andante constant-rate intravenous infusion

Reinforcement Learning Based Model Selection and Parameter Estimation for Pharmacokinetic Analysis in Drug Selection.

Analysis of multidrug effects by parameter method

Large scale compartmental model-based study of preclinical pharmacokinetic data and its impact on compound triaging in drug discovery

A simulation study of sampling time point designing for therapeutic drug monitoring based on a population pharmacokinetic model

Simulation of the Pharmacokinetics of Bisoprolol in Healthy Adults and Patients with Impaired Renal Function Using Whole-Body Physiologically Based Pharmacokinetic Modeling

Predicting nonlinear relationships between external and internal concentrations with physiologically based pharmacokinetic modeling

Applications of model simulation in pharmacological fields and the problems of theoretical reliability

Three-Bottle Exponential Decay Infusion: A Novel Intravenous Infusion Strategy for Drugs Which Conform to Three-Compartment Model with Observations on Propofol Kinetics

A comprehensive analysis of the influence of drug binding kinetics on drug action at molecular and systems levels.

PBPK modeling and simulation in drug research and development

Checking distributional assumptions for pharmacokinetic summary statistics based on simulations with compartmental models

Better prediction of the local concentration-effect relationship: the role of physiologically based pharmacokinetics and quantitative systems pharmacology and toxicology in the evolution of model-informed drug discovery and development